1. Home
  2. WKSP vs EQ Comparison

WKSP vs EQ Comparison

Compare WKSP & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WKSP
  • EQ
  • Stock Information
  • Founded
  • WKSP 2003
  • EQ 2017
  • Country
  • WKSP United States
  • EQ United States
  • Employees
  • WKSP N/A
  • EQ 35
  • Industry
  • WKSP Auto Parts:O.E.M.
  • EQ Biotechnology: Pharmaceutical Preparations
  • Sector
  • WKSP Consumer Discretionary
  • EQ Health Care
  • Exchange
  • WKSP Nasdaq
  • EQ Nasdaq
  • Market Cap
  • WKSP 14.6M
  • EQ 13.1M
  • IPO Year
  • WKSP N/A
  • EQ 2018
  • Fundamental
  • Price
  • WKSP $3.76
  • EQ $0.40
  • Analyst Decision
  • WKSP Strong Buy
  • EQ Buy
  • Analyst Count
  • WKSP 3
  • EQ 3
  • Target Price
  • WKSP $12.83
  • EQ $3.00
  • AVG Volume (30 Days)
  • WKSP 356.4K
  • EQ 553.1K
  • Earning Date
  • WKSP 08-12-2025
  • EQ 08-07-2025
  • Dividend Yield
  • WKSP N/A
  • EQ N/A
  • EPS Growth
  • WKSP N/A
  • EQ N/A
  • EPS
  • WKSP N/A
  • EQ N/A
  • Revenue
  • WKSP $10,211,747.00
  • EQ $30,406,000.00
  • Revenue This Year
  • WKSP $159.92
  • EQ N/A
  • Revenue Next Year
  • WKSP $68.25
  • EQ N/A
  • P/E Ratio
  • WKSP N/A
  • EQ N/A
  • Revenue Growth
  • WKSP 407.96
  • EQ N/A
  • 52 Week Low
  • WKSP $2.44
  • EQ $0.27
  • 52 Week High
  • WKSP $12.00
  • EQ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • WKSP 52.01
  • EQ 56.38
  • Support Level
  • WKSP $3.74
  • EQ $0.36
  • Resistance Level
  • WKSP $4.01
  • EQ $0.45
  • Average True Range (ATR)
  • WKSP 0.55
  • EQ 0.06
  • MACD
  • WKSP -0.05
  • EQ 0.00
  • Stochastic Oscillator
  • WKSP 20.85
  • EQ 59.32

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Share on Social Networks: